Age-related changes in the gene expression profile of antigen-specific mouse CD8+ T cells can be partially reversed by blockade of the BTLA/CD160 pathways during vaccination
Author(s) -
Noor Dawany,
Elizabeth M. Parzych,
Louise C. Showe,
Hildegund C.J. Ertl
Publication year - 2016
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.101105
Subject(s) - btla , cytotoxic t cell , cd8 , cd28 , biology , t cell , immunology , t cell receptor , antigen , blockade , t lymphocyte , virology , microbiology and biotechnology , receptor , immune system , genetics , in vitro
We analyzed gene expression profiles of young and aged mouse CD8 + T cells specific for the nucleoprotein (NP) of influenza A/PR8/34 virus. CD8 + T cells were stimulated either by the NP antigen expressed in its native form or fused into the herpes virus (HSV)-1 glycoprotein D (gD) protein, which blocks signaling through the immunoinhibitory B and T lymphocyte attenuator (BTLA) and CD160 pathways. We show that NP-specific CD8 + T cells from aged mice exhibit numerous differences in gene expression compared to NP-specific CD8 + T cells from young mice, including a significant reduction of expression in genes involved in T cell receptor (TcR) and CD28 signaling. We also show that these changes can be reversed in a sub-population (~50%) of the aged mice by a BTLA/CD160 checkpoint blockade. These results suggest that BTLA/CD160 checkpoint blockade has potential value as a vaccine additive to induce better CD8 + T cell responses in the aged.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom